Financials in USD. Standardized financial statements.
A compact view of how International Stem Cell Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $9.10M | $9.09M | $7.79M | $8.18M | $7.18M | $7.13M | $9.47M | $11.09M | $7.46M | $7.17M |
| Revenue Growth? | +0.2% | +16.6% | -4.8% | +14.0% | +0.7% | -24.7% | -14.6% | +48.7% | +4.1% | 0.0% |
| Cost of Revenue? | $4.03M | $3.76M | $3.18M | $3.27M | $2.94M | $2.78M | $3.93M | $4.07M | $2.12M | $1.94M |
| Gross Profit? | $5.07M | $5.32M | $4.61M | $4.91M | $4.24M | $4.35M | $5.54M | $7.02M | $5.33M | $5.22M |
| Gross Margin? | +55.7% | +58.6% | +59.2% | +60.0% | +59.1% | +61.0% | +58.5% | +63.3% | +71.5% | +72.9% |
| Operating Expenses? | $5.33M | $5.39M | $5.27M | $5.09M | $6.16M | $7.17M | $11.27M | $10.49M | $10.28M | $10.07M |
| Operating Income? | -$267,000 | -$68,000 | -$663,000 | -$196,000 | -$1.92M | -$2.82M | -$5.73M | -$3.47M | -$4.94M | -$4.85M |
| EBITDA? | -$48,000 | $142,000 | $202,000 | $22,000 | -$220,000 | -$2.36M | -$3.90M | -$1.77M | -$5.68M | $186,000 |
| Income Before Tax | -$418,000 | -$209,000 | -$131,000 | -$331,000 | -$899,000 | -$2.72M | -$4.26M | -$2.13M | -$6.07M | -$1.08M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $59,000 | $6,000 |
| Net Income? | -$418,000 | -$209,000 | -$131,000 | -$466,000 | -$1.04M | -$2.84M | -$4.34M | -$2.13M | -$6.07M | -$1.08M |
| EPS? | $-0.05 | $-0.03 | $-0.02 | $-0.06 | $-0.13 | $-0.38 | $-0.58 | $-0.33 | $-1.46 | $-0.34 |
| Diluted EPS? | $-0.05 | $-0.03 | $-0.02 | $-0.06 | $-0.13 | $-0.38 | $-0.58 | $-0.33 | $-1.46 | $-0.34 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality